Insmed (INSM) Misses Q3 EPS by 41c, provide guidance
Tweet
Share
E-mailGet Alerts INSM Hot Sheet
Price: $123.74 -2.05%
Financial Fact:
Research and development: 23.43M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Research and development: 23.43M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Insmed (NASDAQ: INSM) reported Q3 EPS of ($1.75), $0.41 worse than the analyst estimate of ($1.34). Revenue for the quarter came in at $142 million versus the consensus estimate of $114.87 million.
GUIDANCE:
Insmed sees FY2025 revenue of $420-430 million, versus the consensus of $471.3 million.
For earnings history and earnings-related data on Insmed (INSM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Movano (MOVE) Misses Q2 EPS by 195c
- Reading (RDI) Tops Q2 EPS by 4c
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
